Manila Bulletin
DOST-VEP awaiting decision of FDA on 4th Covid-19 vax dose for elderly, immunocompromised
The Department of Health (DOH) has applied to the Food and Drug Administration (FDA) for an amended emergency use authorization (EUA) to allow a fourth dose of COVID-19 vaccines for senior citizens and immunocompromised individuals.
This application follows an initial recommendation from the Vaccine Expert Panel (VEP), which emphasized the importance of administering the fourth dose for these vulnerable groups.
VEP Chairperson Dr. Nina Gloriani cited data from other countries showing that antibodies wane after the first booster, particularly in the immunocompromised and elderly, making a fourth dose crucial for added protection.
Gloriani maintained that a fourth dose is not yet needed for the general population.
The DOH is awaiting the FDA's decision before discussing possible implementation.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The government is considering rolling out a fourth dose of COVID-19 vaccines as early as the last week of April, pending approval from the Food and Drug Administration (FDA).
Read more →
The Philippine College of Chest Physicians (PCCP) supports the recommendation of the vaccine expert panel of the National Task Force (NTF) against COVID-19 to administer a fourth dose or second booster shot to senior citizens and individuals with comorbidities.
Read more →
The Department of Health (DOH) warned the public against taking four or more doses of the COVID-19 vaccine, stating it could be dangerous and is not yet approved by health experts.
Read more →